Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition

This paper seeks to analyse the directive on the application of patients’ rights in cross-border healthcare. Two years after the transposition, it is time for first evaluations of its application, performance and perception. The analysis consists of three major elements: reconstruction of the legal...

Full description

Bibliographic Details
Main Author: Riedel Rafał
Format: Article
Language:English
Published: Sciendo 2016-10-01
Series:Baltic Journal of European Studies
Subjects:
Online Access:https://doi.org/10.1515/bjes-2016-0012
id doaj-2e5cb1f3311f402f91c431ee3ea50b52
record_format Article
spelling doaj-2e5cb1f3311f402f91c431ee3ea50b522021-09-05T20:42:30ZengSciendoBaltic Journal of European Studies2228-05962016-10-0162587510.1515/bjes-2016-0012bjes-2016-0012Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after TranspositionRiedel Rafał0Institute for European Studies, Chemnitz University of Technology, Germany Opole University ul. Katowicka 89, Opole 45-061, PolandThis paper seeks to analyse the directive on the application of patients’ rights in cross-border healthcare. Two years after the transposition, it is time for first evaluations of its application, performance and perception. The analysis consists of three major elements: reconstruction of the legal scope and subject matter of the new legislation, conclusions of the evaluative reports monitoring its implementation and performance as well as the public opinion polls revealing the EU citizens’ perception of its details. These three components combined together deliver a picture of the state of play about the pan-European cross-border patients’ mobility. The bottomline conclusions negatively verify the supposition present in some earlier literature on patients’ cross-border mobility that the directive has a transformative potential leading towards the creation of truly competitive pan-European medical market. After two years of its operation, there is still no increased patients’ mobility across EU internal borders observed. As regards the speculations for the future, there are only some weak symptoms identified and they may result in intensified cross-border mobility for healthcare.https://doi.org/10.1515/bjes-2016-0012cross-border healthcaredirectivepatients’ mobility
collection DOAJ
language English
format Article
sources DOAJ
author Riedel Rafał
spellingShingle Riedel Rafał
Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition
Baltic Journal of European Studies
cross-border healthcare
directive
patients’ mobility
author_facet Riedel Rafał
author_sort Riedel Rafał
title Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition
title_short Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition
title_full Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition
title_fullStr Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition
title_full_unstemmed Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition
title_sort patient’s cross-border mobility directive: application, performance and perceptions two years after transposition
publisher Sciendo
series Baltic Journal of European Studies
issn 2228-0596
publishDate 2016-10-01
description This paper seeks to analyse the directive on the application of patients’ rights in cross-border healthcare. Two years after the transposition, it is time for first evaluations of its application, performance and perception. The analysis consists of three major elements: reconstruction of the legal scope and subject matter of the new legislation, conclusions of the evaluative reports monitoring its implementation and performance as well as the public opinion polls revealing the EU citizens’ perception of its details. These three components combined together deliver a picture of the state of play about the pan-European cross-border patients’ mobility. The bottomline conclusions negatively verify the supposition present in some earlier literature on patients’ cross-border mobility that the directive has a transformative potential leading towards the creation of truly competitive pan-European medical market. After two years of its operation, there is still no increased patients’ mobility across EU internal borders observed. As regards the speculations for the future, there are only some weak symptoms identified and they may result in intensified cross-border mobility for healthcare.
topic cross-border healthcare
directive
patients’ mobility
url https://doi.org/10.1515/bjes-2016-0012
work_keys_str_mv AT riedelrafał patientscrossbordermobilitydirectiveapplicationperformanceandperceptionstwoyearsaftertransposition
_version_ 1717785582366621696